Engineering Next-Generation
Engineering Next-Generation
Antibody Therapeutics
Antibody Therapeutics
Embedded Files
HumiNex is a biotechnology company discovering and
developing innovative antibody therapeutics for
challenging membrane protein targets.
ABOUT HUMINEX
ABOUT HUMINEX
HumiNex focuses on the discovery of best-in-class antibodies against novel targets with high unmet medical needs. We leverage our proprietary platforms to develop differentiated therapeutics for cancer and other diseases.
OUR TECHNOLOGY
OUR TECHNOLOGY
Antibody discovery
Proprietary discovery engine identifies high-quality antibodies against challenging targets.
ADC Platform
Optimized ADC platform with efficient payload delivery and favorable safety profile.
Bispecific Platform
Versatile bispecific antibody platform for immune modulation and targeted therapy.
HumiNex Inc.
6F, Seegene Medical Tower,
288 Dapsimni-ro, Dongdaemun-gu,
Seoul 02637, Republic of Korea
☎ 010-2594-7174
Copyright © 2026 HumiNex Inc.
All rights reserved.
Page updated
Report abuse